Approaches that recruit and activate tumor-infiltrating T cells could help reshape the immunosuppressive tumor microenvironment, making immunotherapy more effective for patients with microsatellite stability and low microsatellite instability colorectal cancers. Oncolytic viruses can offer an alternative to help stimulate the antitumor immunity in ‘cold’ tumors.